what is happening with tirzepatide FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Tirzepatide (Zepbound, Mounjaro): Weight Loss,

Let Us Help You

But the peak severity and the dropout rate suggest that the triple receptor activation, while more effective for weight loss, comes at a real cost in terms of tolerability

kdhe.ks.gov Last updated: January 2026 Reviewed monthly as formularies and coverage policies change Disclaimer The information on this page is for educational and informational purposes only and is not intended as medical advice

Saxenda As for Saxenda, it is also available by prescription, and insurance plans may cover part of the cost

Curr Med Res Opin 1990;11:638-47

Tirzepatide's SURMOUNT-1 curve flattened earlier at a lower ceiling, consistent with a mechanism that primarily caps intake rather than also raising expenditure